Daniel Arias
Stock Analyst at Stifel
(5.00)
# 7
Out of 4,784 analysts
148
Total ratings
55.17%
Success rate
150.94%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Upgrades: Buy | $260 | $205.85 | +26.31% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.73 | +229.67% | 2 | Mar 12, 2025 | |
| GH Guardant Health | Maintains: Buy | $45 → $53 | $43.14 | +22.86% | 2 | Feb 21, 2025 | |
| BRKR Bruker | Maintains: Hold | $70 → $57 | $42.08 | +35.46% | 6 | Feb 14, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $9.16 | +96.51% | 6 | Feb 13, 2025 | |
| AVTR Avantor | Maintains: Buy | $28 → $26 | $16.18 | +60.69% | 8 | Feb 10, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $4.04 | +48.51% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,177.09 | +23.19% | 7 | Nov 11, 2024 | |
| TEM Tempus AI | Downgrades: Hold | $45 → $65 | $47.83 | +35.90% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $67 | $43.66 | +53.46% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $362.16 | -0.60% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $665 | $500.16 | +32.96% | 15 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $116.69 | +29.40% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $39.85 | +16.31% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.36 | +323.73% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $133.41 | +55.16% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $105.62 | +4.15% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $65 | $58.73 | +10.68% | 10 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $80.00 | +150.00% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.81 | +77.94% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.70 | +270.37% | 2 | May 31, 2022 |
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $205.85
Upside: +26.31%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.73
Upside: +229.67%
Guardant Health
Feb 21, 2025
Maintains: Buy
Price Target: $45 → $53
Current: $43.14
Upside: +22.86%
Bruker
Feb 14, 2025
Maintains: Hold
Price Target: $70 → $57
Current: $42.08
Upside: +35.46%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.16
Upside: +96.51%
Avantor
Feb 10, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $16.18
Upside: +60.69%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $4.04
Upside: +48.51%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,177.09
Upside: +23.19%
Tempus AI
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $47.83
Upside: +35.90%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $43.66
Upside: +53.46%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $362.16
Upside: -0.60%
Oct 24, 2024
Maintains: Buy
Price Target: $680 → $665
Current: $500.16
Upside: +32.96%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $116.69
Upside: +29.40%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $39.85
Upside: +16.31%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.36
Upside: +323.73%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $133.41
Upside: +55.16%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $105.62
Upside: +4.15%
Feb 2, 2024
Downgrades: Hold
Price Target: $65
Current: $58.73
Upside: +10.68%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $80.00
Upside: +150.00%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.81
Upside: +77.94%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.70
Upside: +270.37%